Tag Archives: R&D
Cartoon – Turning a Liar into a Thief
Microsoft wades into healthcare R&D. What’s behind this trend?
- Microsoft is engaged in numerous health research projects in a mutually beneficial relationship with the medical community, according to an article on the Microsoft website.
- One Microsoft project is using machine learning to sift through massive amounts of data on cancer biology to make precision medicine more possible. Another is a cloud-based tool that creates computerized models of biological processes associated with cancer progression.
- Microsoft’s excursion into medical research is just one of many made in the recent past by technology companies not typically associated with healthcare.
Drug Regulation and Pricing — Can Regulators Influence Affordability?
Public debate in the 1990s over drugs’ clinical toxicity has given way to concerns about their financial toxicity. Although drug regulators aren’t supposed to be concerned with pricing, they’ve been drawn into an acrimonious debate over the cost of medicines.
America’s Secret Weapon
What is new is that more countries than ever are competing for global leadership, and they know the value of innovation. Since 2000, South Korea’s research and development spending (measured as a percentage of GDP) has gone up 90 percent. China’s has doubled. The United States’ has essentially flatlined. It’s great that the rest of the world is committing more, but if the United States is going to maintain its leading role, it needs to up its game.
HENRY KOTULA 